LumiraDx UK Limited Evaluates POC Test for COVID-19 Symptoms
LumiraDx UK Limited is conducting a trial to evaluate a point-of-care test for COVID-19 using nasal and blood samples.
Indication
Clinical and regulatory intelligence for COVID-19 with 11 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.